BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear.METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively.RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart.CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.
%0 Journal Article
%1 d794189948e74d74982cbaceea556372
%A Vasudevan, Praveen
%A Wolfien, Markus
%A Lemcke, Heiko
%A Lang, Cajetan Immanuel
%A Skorska, Anna
%A Gaebel, Ralf
%A Galow, Anne-Marie
%A Koczan, Dirk
%A Lindner, Tobias
%A Bergmann, Wendy
%A Mueller-Hilke, Brigitte
%A Vollmar, Brigitte
%A Krause, Bernd Joachim
%A Wolkenhauer, Olaf
%A Steinhoff, Gustav
%A David, Robert
%D 2023
%I BioMed Central, London
%J Genome medicine
%K FIS_scads topic_lifescience yaff
%N 1
%R 10.1186/s13073-023-01213-3
%T CCR2 macrophage response determines the functional outcome following cardiomyocyte transplantation
%V 15
%X BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear.METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively.RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart.CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.
@article{d794189948e74d74982cbaceea556372,
abstract = {BACKGROUND: The immune response is a crucial factor for mediating the benefit of cardiac cell therapies. Our previous research showed that cardiomyocyte transplantation alters the cardiac immune response and, when combined with short-term pharmacological CCR2 inhibition, resulted in diminished functional benefit. However, the specific role of innate immune cells, especially CCR2 macrophages on the outcome of cardiomyocyte transplantation, is unclear.METHODS: We compared the cellular, molecular, and functional outcome following cardiomyocyte transplantation in wildtype and T cell- and B cell-deficient Rag2del mice. The cardiac inflammatory response was assessed using flow cytometry. Gene expression profile was assessed using single-cell and bulk RNA sequencing. Cardiac function and morphology were determined using magnetic resonance tomography and immunohistochemistry respectively.RESULTS: Compared to wildtype mice, Rag2del mice show an increased innate immune response at steady state and disparate macrophage response after MI. Subsequent single-cell analyses after MI showed differences in macrophage development and a lower prevalence of CCR2 expressing macrophages. Cardiomyocyte transplantation increased NK cells and monocytes, while reducing CCR2-MHC-IIlo macrophages. Consequently, it led to increased mRNA levels of genes involved in extracellular remodelling, poor graft survival, and no functional improvement. Using machine learning-based feature selection, Mfge8 and Ccl7 were identified as the primary targets underlying these effects in the heart.CONCLUSIONS: Our results demonstrate that the improved functional outcome following cardiomyocyte transplantation is dependent on a specific CCR2 macrophage response. This work highlights the need to study the role of the immune response for cardiomyocyte cell therapy for successful clinical translation.},
added-at = {2024-11-28T16:27:18.000+0100},
author = {Vasudevan, Praveen and Wolfien, Markus and Lemcke, Heiko and Lang, {Cajetan Immanuel} and Skorska, Anna and Gaebel, Ralf and Galow, Anne-Marie and Koczan, Dirk and Lindner, Tobias and Bergmann, Wendy and Mueller-Hilke, Brigitte and Vollmar, Brigitte and Krause, {Bernd Joachim} and Wolkenhauer, Olaf and Steinhoff, Gustav and David, Robert},
biburl = {https://puma.scadsai.uni-leipzig.de/bibtex/29a1b18045dd99caf7d58385620549516/scadsfct},
day = 10,
doi = {10.1186/s13073-023-01213-3},
interhash = {6fc044457d368f713da7f774fddd5b93},
intrahash = {9a1b18045dd99caf7d58385620549516},
issn = {1756-994X},
journal = {Genome medicine},
keywords = {FIS_scads topic_lifescience yaff},
language = {English},
month = aug,
note = {Publisher Copyright: {\textcopyright} 2023, BioMed Central Ltd., part of Springer Nature.},
number = 1,
publisher = {BioMed Central, London},
timestamp = {2025-07-29T10:29:43.000+0200},
title = {CCR2 macrophage response determines the functional outcome following cardiomyocyte transplantation},
volume = 15,
year = 2023
}